Treatment strategies for breast cancer are tailored according to the expression of estrogen receptor (ER), progesterone receptor (PR), human epidermal growth factor 2 (HER2), and Ki-67 (the proliferation marker) [2]. This evidence concerns the gene MKI67 and breast carcinoma.